Clinical Trial Update: This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics and safety of IBI362 in Chinese adolescents with obesity; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• IBI362

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Adolescents With Obesity | Phase 1 | Status: COMPLETED